These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31944842)

  • 1. Transferring Racial/Ethnic Marketing Strategies From Tobacco to Food Corporations: Philip Morris and Kraft General Foods.
    Nguyen KH; Glantz SA; Palmer CN; Schmidt LA
    Am J Public Health; 2020 Mar; 110(3):329-336. PubMed ID: 31944842
    [No Abstract]   [Full Text] [Related]  

  • 2. A historical review of R.J. Reynolds' strategies for marketing tobacco to Hispanics in the United States.
    Iglesias-Rios L; Parascandola M
    Am J Public Health; 2013 May; 103(5):e15-27. PubMed ID: 23488493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobacco industry consumer research on smokeless tobacco users and product development.
    Mejia AB; Ling PM
    Am J Public Health; 2010 Jan; 100(1):78-87. PubMed ID: 19910355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Turning free speech into corporate speech: Philip Morris' efforts to influence U.S. and European journalists regarding the U.S. EPA report on secondhand smoke.
    Muggli ME; Hurt RD; Becker LB
    Prev Med; 2004 Sep; 39(3):568-80. PubMed ID: 15313097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Gone are the days of mass-media marketing plans and short term customer relationships": tobacco industry direct mail and database marketing strategies.
    Lewis MJ; Ling PM
    Tob Control; 2016 Jul; 25(4):430-6. PubMed ID: 26243810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARTIST (Asian regional tobacco industry scientist team): Philip Morris' attempt to exert a scientific and regulatory agenda on Asia.
    Tong EK; Glantz SA
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii118-24. PubMed ID: 15564214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco industry involvement in children's sugary drinks market.
    Nguyen KH; Glantz SA; Palmer CN; Schmidt LA
    BMJ; 2019 Mar; 364():l736. PubMed ID: 30872273
    [No Abstract]   [Full Text] [Related]  

  • 8. Social identity and support for counteracting tobacco company marketing that targets vulnerable populations.
    Baig SA; Pepper JK; Morgan JC; Brewer NT
    Soc Sci Med; 2017 Jun; 182():136-141. PubMed ID: 28427731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncovering Philip Morris International's Fundamental Strategies for Product Placement in Thailand: Spotlighting Industry Penetration to Advance the Endgame.
    Charoenca N; Kungskulniti N; Hamann S; Mock J
    Asian Pac J Cancer Prev; 2021 Dec; 22(12):3789-3801. PubMed ID: 34967557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marketing of menthol cigarettes and consumer perceptions: a review of tobacco industry documents.
    Anderson SJ
    Tob Control; 2011 May; 20 Suppl 2(Suppl_2):ii20-8. PubMed ID: 21504928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making big tobacco give in: you lose, they win.
    Wander N; Malone RE
    Am J Public Health; 2006 Nov; 96(11):2048-54. PubMed ID: 17018823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public versus internal conceptions of addiction: An analysis of internal Philip Morris documents.
    Elias J; Hendlin YH; Ling PM
    PLoS Med; 2018 May; 15(5):e1002562. PubMed ID: 29715300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The context for choice: health implications of targeted food and beverage marketing to African Americans.
    Grier SA; Kumanyika SK
    Am J Public Health; 2008 Sep; 98(9):1616-29. PubMed ID: 18633097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Philip Morris unlocked the Japanese cigarette market: lessons for global tobacco control.
    Lambert A; Sargent JD; Glantz SA; Ling PM
    Tob Control; 2004 Dec; 13(4):379-87. PubMed ID: 15564622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco industry marketing to low socioeconomic status women in the U.S.A.
    Brown-Johnson CG; England LJ; Glantz SA; Ling PM
    Tob Control; 2014 Nov; 23(e2):e139-46. PubMed ID: 24449249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From adversary to target market: the ACT-UP boycott of Philip Morris.
    Offen N; Smith EA; Malone RE
    Tob Control; 2003 Jun; 12(2):203-7. PubMed ID: 12773732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Philip Morris research on precursors to the modern e-cigarette since 1990.
    Dutra LM; Grana R; Glantz SA
    Tob Control; 2017 Dec; 26(e2):e97-e105. PubMed ID: 27852893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Philip Morris Nordic journalist program: strategies, implementation and outcomes.
    Hiilamo H; Kahl U; Lambe M
    Health Policy; 2009 Jan; 89(1):84-96. PubMed ID: 18582983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobacco industry documents from outside sources: new perspectives on industry strategies on local levels.
    Hiilamo H; Hirschhorn N
    Cent Eur J Public Health; 2006 Dec; 14(4):175-9. PubMed ID: 17243496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Living Tomorrow Project: how Philip Morris has used a Belgian tourist attraction to promote ventilation approaches to the control of second hand smoke.
    Pilkington P; Gilmore AB
    Tob Control; 2004 Dec; 13(4):375-8. PubMed ID: 15564621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.